Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
about
Stathmin is dispensable for tumor onset in miceRac and Rho GTPases in cancer cell motility controlMicroRNA-9 coordinates proliferation and migration of human embryonic stem cell-derived neural progenitorsReduced expression of the ROCK inhibitor Rnd3 is associated with increased invasiveness and metastatic potential in mesenchymal tumor cellsTumor-associated Endo180 requires stromal-derived LOX to promote metastatic prostate cancer cell migration on human ECM surfaces.Role of T198 modification in the regulation of p27(Kip1) protein stability and functionInitial steps of metastasis: cell invasion and endothelial transmigrationPAK4 kinase-mediated SCG10 phosphorylation involved in gastric cancer metastasisPlasticity of cell migration: a multiscale tuning modelInhibition of breast cancer metastasis suppressor 1 promotes a mesenchymal phenotype in lung epithelial cells that express oncogenic K-RasV12 and loss of p53.The tumor suppressor functions of p27(kip1) include control of the mesenchymal/amoeboid transition.p27kip1 controls cell morphology and motility by regulating microtubule-dependent lipid raft recycling.Gene expression profiles in mouse embryo fibroblasts lacking stathmin, a microtubule regulatory protein, reveal changes in the expression of genes contributing to cell motility.Protein pattern of Xenopus laevis embryos grown in simulated microgravity.The insulin-like growth factor receptor I promotes motility and invasion of bladder cancer cells through Akt- and mitogen-activated protein kinase-dependent activation of paxillin.Nicotine-mediated invasion and migration of non-small cell lung carcinoma cells by modulating STMN3 and GSPT1 genes in an ID1-dependent manner.Paxillin inhibits HDAC6 to regulate microtubule acetylation, Golgi structure, and polarized migration.Polyploid giant cancer cells with budding and the expression of cyclin E, S-phase kinase-associated protein 2, stathmin associated with the grading and metastasis in serous ovarian tumor.Stathmin1 plays oncogenic role and is a target of microRNA-223 in gastric cancer.Congestive heart failure effects on atrial fibroblast phenotype: differences between freshly-isolated and cultured cellsAutomated method for the rapid and precise estimation of adherent cell culture characteristics from phase contrast microscopy images.Anti-centrosome antibodies in breast cancer are the expression of autoimmunity.Changes in the nasopharyngeal carcinoma nuclear proteome induced by the EBNA1 protein of Epstein-Barr virus reveal potential roles for EBNA1 in metastasis and oxidative stress responses.Regulation of microtubule dynamics by DIAPH3 influences amoeboid tumor cell mechanics and sensitivity to taxanesDown-regulation of Stathmin Is Required for the Phenotypic Changes and Classical Activation of Macrophages.Stathmin and phospho-stathmin protein signature is associated with survival outcomes of breast cancer patients.PIWIL1 destabilizes microtubule by suppressing phosphorylation at Ser16 and RLIM-mediated degradation of Stathmin1.Stathmin is involved in the cooperative effect of Zoledronic acid and gefitinib on bone homing breast cancer cells in vitro.Expression and phosphorylation of stathmin correlate with cell migration in esophageal squamous cell carcinoma.Proepithelin is an autocrine growth factor for bladder cancerPAK signaling in oncogenesis.RSK2 signals through stathmin to promote microtubule dynamics and tumor metastasisThe molecular mechanisms of transition between mesenchymal and amoeboid invasiveness in tumor cells.The cytotoxic effect of memantine and its effect on cytoskeletal proteins expression in metastatic breast cancer cell line.p27kip1 expression limits H-Ras-driven transformation and tumorigenesis by both canonical and non-canonical mechanisms.Enhanced shedding of extracellular vesicles from amoeboid prostate cancer cells: potential effects on the tumor microenvironment.Stathmin decreases cholangiocarcinoma cell line sensitivity to staurosporine-triggered apoptosis via the induction of ERK and Akt signaling.Microtubule-targeting agents in oncology and therapeutic potential in hepatocellular carcinoma.Stathmin: a protein with many tasks. New biomarker and potential target in cancer.Small Rho GTPases in the control of cell shape and mobility.
P2860
Q21134036-90AE5E9A-2BB6-4886-9D35-09A62D77E45CQ21245504-AE8CA7D6-6F5C-44EF-81E6-6EDEB204CCB4Q24601338-D524A3EA-C3C7-413B-AF15-E2140461EACBQ27316195-E1986570-E1BA-4D87-AF36-B95342035D76Q27316928-FCFD971A-4883-4183-ADEA-3BCFEF08B42CQ27349944-73EA51C0-99D0-4F3F-B5FE-282D4E03E57EQ28238397-1A33541A-E4A9-484B-8A24-1A58E9096834Q28295467-53260575-024B-4E5E-9D31-C55A84969016Q29620332-D955279A-86A2-42FA-98BF-6D262687A628Q30413635-44D5C15A-7330-4558-A73E-877B2D5193B8Q30490003-DC57D8BC-F6F5-40A6-B10A-9E0504B9ECBAQ30494330-8FD13096-4C36-4617-9C20-ED8299EA6ADBQ33488716-7B78261E-AE81-4ED8-A0EB-85DB7CDD9BAEQ33718434-008607BA-8F4B-49A1-8379-891600A88683Q33882569-F8E08B7B-18BE-454F-B458-3D4DA9014B11Q34000136-840112B4-6E24-47CE-B745-026213973E8BQ34003129-646B3F4A-F966-43D9-A94A-216982665DDAQ34062677-22903E46-3F84-43C7-9291-4B99B0A2D316Q34217592-C6280ACA-0D71-4DC9-ADF0-6D836475AC7FQ34517528-3F42A7D5-9AB6-476E-95FF-9F2AC46ADE8AQ34987570-1B70CDD8-B623-47F7-88B2-9812CCA02089Q35446906-E8F61F5F-3634-45CD-AE2F-96B4DD58625AQ35665976-E8BA187F-B3FD-49CB-BE3A-551B9B538A29Q35856517-BA6D48A8-DA22-45C9-97B0-C47DC9D32A58Q35905393-9448B233-352C-437D-900F-969B21A8A1ADQ36355929-21BC7410-E41D-4926-A84F-08D76A05DF86Q36413910-3447D340-EA88-4E32-83F2-4B5EE31C947FQ36491391-93996B73-5DBC-46C3-B6FE-26F8F633A2FFQ36642789-EF35C8A6-DD1D-472B-A67F-6857845F5DE6Q37175488-30BADE65-8061-4336-BC78-9F8D93A1F389Q37494233-B1F2E982-5842-492A-A136-8442FF44AF5AQ37579739-1A0437AA-917C-4B6E-AE02-AEF3A088E3CAQ37587029-188D0CD1-B7E2-424D-A4CA-838083BEF54AQ37592867-A2D06129-AEEF-44CA-A7FB-B8D6752D9E60Q37662085-B827A887-65AC-4647-A3D3-3F42A682F0C5Q37692454-5A385E99-9AF8-44FB-AC76-5E9BDA848270Q37716616-EA43E1FC-F5E6-4A90-9E11-A0279F8B7B4CQ37722656-75D6B8A8-CA5B-4643-ACD9-09E6F8AC5029Q37942978-F026CB2D-1204-4FA9-9EC8-1EC23CE9F1BEQ38166254-7793F113-9060-4483-9638-E4D1FB9737D6
P2860
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
@ast
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
@en
type
label
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
@ast
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
@en
prefLabel
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
@ast
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential.
@en
P2093
P2860
P50
P356
P1476
Stathmin activity influences sarcoma cell shape, motility, and metastatic potential
@en
P2093
Francesca Lovat
Katarina Wolf
Milena S Nicoloso
Sara D'Andrea
Stefania Berton
P2860
P304
P356
10.1091/MBC.E07-09-0894
P50
P577
2008-02-27T00:00:00Z